Denosumab (brand name Prolia for osteoporosis, Xgeva for bone metastasis applications, Amgen) is a fully human monoclonal antibody targeting RANKL (receptor activator of nuclear factor κB ligand). RANKL is the principal cytokine driving osteoclast…